GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Gross-Profit-to-Asset %

Glycorex Transplantation AB (NGM:GTAB B) Gross-Profit-to-Asset % : 64.50% (As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Glycorex Transplantation AB's annualized Gross Profit for the quarter that ended in Dec. 2024 was kr33.58 Mil. Glycorex Transplantation AB's average Total Assets over the quarter that ended in Dec. 2024 was kr52.06 Mil. Therefore, Glycorex Transplantation AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 64.50%.


Glycorex Transplantation AB Gross-Profit-to-Asset % Historical Data

The historical data trend for Glycorex Transplantation AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Gross-Profit-to-Asset % Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.81 23.25 31.88 33.17 48.60

Glycorex Transplantation AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.43 42.94 49.39 39.21 64.50

Competitive Comparison of Glycorex Transplantation AB's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Glycorex Transplantation AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glycorex Transplantation AB's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glycorex Transplantation AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Glycorex Transplantation AB's Gross-Profit-to-Asset % falls into.


;
;

Glycorex Transplantation AB Gross-Profit-to-Asset % Calculation

Glycorex Transplantation AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=28.224/( (65.844+50.304)/ 2 )
=28.224/58.074
=48.60 %

Glycorex Transplantation AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=33.576/( (53.813+50.304)/ 2 )
=33.576/52.0585
=64.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Glycorex Transplantation AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glycorex Transplantation AB Business Description

Traded in Other Exchanges
Address
Solvegatan 41, Lund, SWE, 223 70
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines